{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-014901","form_type":"8-K","ticker":"AZTA","cik":"0000933974","company_name":"Azenta, Inc.","filed_at":"2025-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.878779+00:00","generated_at":"2026-05-22T10:24:11.167714+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Azenta Q2 revenue $143M up 5% YoY; reaffirms FY2025 guidance","bullets":["Revenue $143M (+5% YoY, organic +6%); Sample Mgmt Solutions $80M (+8%), Multiomics $64M (+2%).","GAAP diluted EPS from continuing ops -$0.40 (vs -$0.29); total diluted EPS -$0.88 (vs -$2.47).","Non-GAAP diluted EPS $0.05 (vs $0.06); Adjusted EBITDA $14M, margin 10.0% (up 400bps YoY).","Cash & marketable securities $540M; operating cash flow $14M, free cash flow $7M in quarter.","FY2025 guidance reaffirmed: organic revenue growth 3–5%, Adjusted EBITDA margin expansion ~300 bps."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-014901","json":"https://secwatch.observer/filing/0001437749-25-014901.json","markdown":"https://secwatch.observer/filing/0001437749-25-014901.md","text":"https://secwatch.observer/filing/0001437749-25-014901.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/933974/000143774925014901/0001437749-25-014901-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/933974/000143774925014901/azta20250217_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T10:24:11.167714+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}